Skip to main content
. 2016 Mar 18;150(1):80–90. doi: 10.1016/j.chest.2016.03.002

Table 2.

Effect of CPAP Treatment on Cardiovascular Biomarkers, Intent to Treat (Change of Biomarker From Baseline)

Outcome Sham (n = 71) CPAP (n = 72) P Value
Oxidative stress/inflammation biomarkers
 F2-isoprostanes/Cra −0.02 (−0.12 to 0.10) −0.08 (−0.18 to 0.03) .38
 Myeloperoxidase, pmol/L −3.33 (−17.02 to 10.37) −5.15 (−18.65 to 8.35) .85
 Lipoprotein (a), mg/dL 0.00 (−0.01 to 0.02) 0.00 (−0.01 to 0.02) .99
 Oxidized LDL, U/L −1.38 (−2.69 to −0.07) −1.34 (−2.64 to −0.03) .96
 Paraoxonase, U/mL 1.37 (−55.91 to 58.64) −17.02 (−73.03 to 38.99) .65
 Aryl esterase, nmol/min/mL −0.92 (−6.47 to 4.63) −5.74 (−11.16 to −0.31) .22
 sIL-6Ra 0.02 (−0.02 to 0.06) −0.04 (−0.08 to −0.01) .019
 IL-6 (pg/mL) 0.29 (−0.10 to 0.68) −0.08 (−0.46 to 0.29) .17
Arterial stiffness measures
 AIx, evening, % −0.43 (−3.87 to 3.00) −1.79 (−5.36 to 1.78) .59
 AIx, morning, % 0.44 (−2.22 to 3.10) −6.49 (−9.32 to −3.65) < .001
 Augmentation pressure, evening, mm Hg 0.36 (−0.90 to 1.63) −0.18 (−1.52 to 1.15) .56
 Augmentation pressure, morning, mm Hg 0.34 (−1.03 to 1.72) −1.46 (−2.98 to 0.07) .085
 Pulse wave velocity, evening, cm/s −0.08 (−0.57 to 0.40) −0.30 (−0.80 to 0.20) .55
 Pulse wave velocity, morning, cm/s −0.25 (−0.82 to 0.32) −0.42 (−1.01 to 0.16) .68
BP
 SBP, evening, mm Hg −0.95 (−3.59 to 1.69) −0.41 (−3.03 to 2.21) .78
 SBP, morning, mm Hg 0.17 (−2.44 to 2.78) −3.44 (−6.03 to −0.85) .054
 DBP, evening, mm Hg −0.45 (−2.52 to 1.61) −0.83 (−2.88 to 1.22) .80
 DBP, morning, mm Hg 0.11 (−1.73 to 1.94) −1.37 (−3.19 to 0.46) .27
 Mean arterial BP, evening, mm Hg −0.59 (−2.53 to 1.35) −0.72 (−2.65 to 1.20) .92
 Mean arterial BP, morning, mm Hg 0.24 (−1.64 to 2.12) −2.17 (−4.03 to −0.30) .076

Results are least square means and 95% CI of absolute change from baseline, with adjustment of baseline. See Table 1 legend for expansion of abbreviations.

a

Data was log-transformed for analysis and transformed back for presentation. The findings reflect the percentage change (ie, the percent of change at week 8 to baseline values).